Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ALL

Market Volatility – Understanding the Reasons Behind Today's Share Price Declines

This afternoon we watched Allstate drop -3.1% to a price of $207.02 per share. The Large-Cap Property & Casualty Insurance company is now trading -9.87% below its average target price of $229.68. Analysts have set target prices ranging from $157.0 to $275.0 per share for Allstate, and have given the stock an average rating of buy.

The stock has a very low short interest at 1.4%, and a short ratio of 1.86. The company's insiders own 0.58% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 81.6% of Allstate's shares being owned by this investor type.

Institutions Invested in Allstate

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 13% 33,235,231 $6,880,357,663
2025-06-30 Blackrock Inc. 9% 22,538,850 $4,665,992,823
2025-06-30 Price (T.Rowe) Associates Inc 6% 15,590,671 $3,227,580,777
2025-06-30 State Street Corporation 4% 11,774,049 $2,437,463,674
2025-06-30 Geode Capital Management, LLC 3% 6,714,629 $1,390,062,524
2025-06-30 Bank of America Corporation 2% 6,596,614 $1,365,631,058
2025-06-30 Franklin Resources, Inc. 2% 4,670,113 $966,806,813
2025-06-30 Morgan Stanley 2% 4,580,112 $948,174,805
2025-06-30 GQG Partners LLC 2% 4,311,336 $892,532,797
2025-06-30 Invesco Ltd. 1% 3,359,099 $695,400,689

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Allstate.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS